Blocking Key Signaling Chemical in the Immune System Stalls Chronic Inflammation and Insulin Resistance Tied to Obesity
Researchers at NYU Langone Medical Center have found that blocking the action of a key signaling molecule in the immune system known as Netrin-1 stalls chronic inflammation and insulin resistance tied to obesity and often derived from fatty diets.
NYU Langone Medical Center’s Steven J. Burden, PhD, and Oliver Sacks, MD, Elected 2013 Fellows of American Association for the Advancement of Science (AAAS)
NIH Awards $10 Million Grant To NYU Langone Medical Center To Study Management Of Ischemic Heart Disease In Patients With Chronic Kidney Disease
Genetics Pioneer Rochelle Hirschhorn, MD, Honored with American Society of Human Genetics 2013 Victor McKusick Leadership Award
Experts from NYU Langone Present New Research at American College of Rheumatology 2013 Annual Meeting
Experts from NYU Langone’s Department of Medicine, Division of Rheumatology presented new research and participated in expert panel discussions at the American College of Rheumatology 2013 Annual Meeting in San Diego, CA, October 26-30.